Jun Yin | Organizational behavior | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Jun Yin
Affiliation Shenzhen University
Country China
Scopus ID 57222541034
Documents 8
Citations 81
h-index 4
Subject Area Organizational behavior
Event Global HRM Awards

Jun Yin
Shenzhen University, Shenzhen, China

Jun Yin is a management scholar whose research explores organizational theories, workplace psychology, paradox mindset, mentoring, employee engagement, artificial intelligence in organizations, and knowledge management. His academic profile reflects interdisciplinary contributions that connect behavioral science with contemporary management challenges, particularly in the context of organizational learning, innovation, leadership, and employee performance.[1][2]

Abstract

This article presents an academic profile of Jun Yin, Assistant Professor at Shenzhen University. His scholarly work focuses on paradox mindset, organizational learning, mentoring, employee engagement, artificial intelligence in the workplace, and employee adaptive performance. Through publications in recognized management and behavioral science journals, he has contributed to contemporary discussions on leadership, innovation, knowledge renewal, and workplace dynamics.[1][3]

Keywords

Paradox Mindset; Organizational Learning; Artificial Intelligence; Employee Engagement; Mentoring; Knowledge Management; Leadership; Innovation; Adaptive Performance; Workplace Psychology.

Introduction

The growing complexity of modern organizations has increased scholarly interest in paradox theory, organizational behavior, and technology-enabled workplace transformation. Jun Yin’s research addresses these themes by examining how individuals and organizations navigate tensions, embrace learning, and adapt to emerging technological developments such as generative artificial intelligence.[4]

Research Profile

Jun Yin serves as Assistant Professor at Shenzhen University. His academic training includes doctoral studies in management at Hokkaido University, graduate education at the University of Leeds, and undergraduate studies at Lanzhou University. His interdisciplinary research integrates management theory, psychology, leadership studies, and organizational development.[1]

Research Contributions

His research contributions include advancing understanding of paradox mindset in organizations, explaining mechanisms that influence employee engagement and unlearning, examining leadership behaviors that foster adaptive capabilities, and investigating the organizational implications of artificial intelligence adoption. These studies contribute to both theoretical development and practical management applications.[4][5]

Publications

Selected publications include studies on generative AI stressors and employee adaptive performance, AI-enabled knowledge renewal, paradox mindset and workplace unlearning, paradoxical leadership, mentoring effectiveness, and employee engagement. These works have appeared in journals such as Journal of Knowledge Management, Asia Pacific Journal of Human Resources, Current Psychology, and Leadership & Organization Development Journal.[3][4][5]

Research Impact

According to Scopus author metrics, Jun Yin has accumulated 81 citations across 8 indexed publications and holds an h-index of 4. These indicators reflect measurable scholarly visibility and engagement within the fields of management and organizational studies.[2]

Award Suitability

Jun Yin’s body of work demonstrates sustained engagement with contemporary organizational challenges, including leadership, innovation, learning processes, and AI-driven workplace transformation. His publication record, citation performance, and international academic background support consideration for recognition within research excellence and management scholarship categories.[1][2]

Conclusion

The academic profile of Jun Yin highlights a developing research portfolio focused on organizational behavior, management theory, and emerging workplace technologies. His contributions continue to expand scholarly understanding of paradox mindset, employee adaptation, and organizational learning within evolving business environments.[1][3]

References

  1. ORCID. (2026). Jun Yin (0000-0003-4799-4025) researcher profile. 

    https://orcid.org/0000-0003-4799-4025

  2. Elsevier. (2026). Scopus author details: Jun Yin, Author ID 57222541034. 

    https://www.scopus.com/authid/detail.uri?authorId=57222541034

  3. Yin, J., & Wang, Y. (2026). The Paradoxical Effects of Generative Artificial Intelligence Induced Stressors on Employee Adaptive Performance.https://doi.org/10.1111/1744-7941.70074
  4. Yin, J., & Hoang, K. D. (2025). AI-enabled knowledge renewal: the role of leaders’ AI attitudes and unlearning in enhancing employees’ creative.https://doi.org/10.1108/JKM-02-2025-0209
  5. Yin, J. (2023). Effects of the paradox mindset on work engagement: The mediating role of seeking challenges and individual .

    https://doi.org/10.1007/s12144-021-01597-8

Changgui Li | Gout | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Changgui Li
Affiliation Xiamen University
Country China
Scopus ID 35313424500
Documents 100+
Citations 29
h-index 3
Subject Area  Gout
Event Global HRM Awards

Changgui Li
Xiamen University,  China

Changgui Li is a researcher recognized for scholarly contributions in rheumatology, gout research, hyperuricemia, metabolomics, inflammatory disease mechanisms, renal complications, and translational medicine. His publication record demonstrates active participation in collaborative scientific investigations related to gout pathogenesis, metabolic disorders, therapeutic interventions, biomarker discovery, and genomic analyses.[1]

His research activities include studies involving metabolomics, genome-wide association analyses, inflammatory biomarkers, clinical cohort investigations, and therapeutic evaluations associated with gout and metabolic diseases.[2]

Abstract

Changgui Li has contributed to the advancement of rheumatology and metabolic disease research through investigations involving gout pathophysiology, hyperuricemia, metabolomics, inflammatory biomarkers, renal complications, microbiota regulation, and therapeutic response evaluation. His studies integrate clinical investigations, genomic analyses, metabolomic profiling, machine learning approaches, and translational medicine methodologies for improved understanding of gout-related disorders.[3]

Keywords

Rheumatology; Gout; Hyperuricemia; Metabolomics; Biomarkers; Genome-Wide Association Studies; Inflammatory Diseases; Renal Function; Precision Medicine; Clinical Research.

Introduction

Gout and hyperuricemia represent significant public health concerns associated with inflammatory responses, renal dysfunction, metabolic abnormalities, and chronic disease progression. Contemporary rheumatology research increasingly focuses on biomarker discovery, metabolic profiling, precision medicine, and therapeutic optimization for improved patient outcomes.[4]

Research Profile

The research profile of Changgui Li includes scholarly publications in rheumatology, inflammatory diseases, metabolomics, endocrinology, nephrology, and clinical medicine journals. His work has appeared in Arthritis and Rheumatology, Arthritis Research and Therapy, Rheumatology, Frontiers in Endocrinology, Annals of Medicine, Chemosphere, and other indexed scientific journals.[6]

Research Contributions

Changgui Li has contributed to studies investigating metabolic biomarkers associated with gout flares, obesity-related disease mechanisms, renal urate underexcretion, inflammatory responses, and microbiota-mediated metabolic regulation.[5]

His collaborative investigations additionally include genome-wide association analyses involving large international cohorts, machine learning-assisted predictive models, therapeutic comparative effectiveness studies, and epidemiological analyses examining disease prevalence and clinical outcomes.

Publications

  • Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares, Arthritis and Rheumatology, 2023.
  • Novel genetic loci in adolescent-onset gout derived from whole genome sequencing of a Chinese cohort, medRxiv, 2023.
  • Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout, Rheumatology, 2023.
  • A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with gout, Arthritis Research and Therapy, 2022.
  • Kidney and plasma metabolomics provide insights into the molecular mechanisms of urate nephropathy in a mouse model of hyperuricemia, Biochimica et Biophysica Acta – Molecular Basis of Disease, 2022.
  • Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion, Arthritis and Rheumatology, 2022.

Research Impact

The research contributions of Changgui Li support advancements in rheumatology, metabolic disease management, inflammatory biomarker discovery, metabolomic profiling, microbiota regulation, and precision medicine approaches. His studies contribute to improved understanding of gout progression, renal complications, metabolic dysfunction, and therapeutic response mechanisms

Award Suitability

Changgui Li demonstrates a sustained research profile in rheumatology and metabolic medicine through publication activity, international collaboration, translational investigations, and interdisciplinary scientific contributions. His work aligns with research excellence recognition criteria emphasizing scientific quality, innovation, clinical relevance, and evidence-based medical advancement.

Conclusion

The scholarly activities of Changgui Li contribute to the advancement of gout research, metabolomics, inflammatory disease understanding, and translational rheumatology science. His research demonstrates ongoing engagement in multidisciplinary investigations focused on improving clinical understanding and therapeutic approaches for metabolic and inflammatory disorders.

References

  1. ORCID. (2026). Changgui Li ORCID profile and scholarly activities.
    https://orcid.org/0000-0002-4622-3731
  2. Elsevier Scopus. (2026). Indexed research publications and collaborative studies associated with Changgui Li.
    https://www.scopus.com/authid/detail.uri?authorId=57252600000
  3. Arthritis and Rheumatology. (2023). Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
    https://doi.org/10.1002/art.42635
  4. Annals of Medicine. (2022). Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies.
    https://doi.org/10.1080/07853890.2022.2083670
  5. Acta Pharmaceutica Sinica B. (2023). Pathophysiology of obesity and its associated diseases.
    https://doi.org/10.1016/j.apsb.2023.01.012
  6. Rheumatology (United Kingdom). (2023). Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout.
    https://doi.org/10.1093/rheumatology/keac507